Radionuclide treatment of neuroendocrine tumours with the novel radiolabelled analogue Y-90-SMT 487

Radionuclide treatment of neuroendocrine tumours with the novel radiolabelled analogue Y-90-SMT 487

书目详细资料
Main Authors:	Carroll, P, Maher, K, Foley, R, Stewart, P, Bevan, J, Franklyn, J, Besser, G, Monson, J, Britton, K, Grossman, AB
格式:	Journal article
出版:	2003

相似书籍

Imaging neuroendocrine tumours with radiolabelled somatostatin analogues and X-ray computed tomography: a comparative study.
由: King, C, et al.
出版: (1993)

Localization of neuroendocrine tumours and insulinomas using radiolabelled somatostatin analogues, 123I-Tyr3-octreotide and 111In-pentatreotide.
由: Ur, E, et al.
出版: (1993)

Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues.
由: Kaltsas, G, et al.
出版: (2005)

Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
由: Kaltsas, G, et al.
出版: (2001)

The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours.
由: Kaltsas, G, et al.
出版: (2001)

Advances in Radionuclides and Radiolabelled Peptides for Cancer Therapeutics
由: Kushal Chakraborty, et al.
出版: (2023-03-01)

Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide.
由: Kaltsas, G, et al.
出版: (1998)

The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging.
由: Johnston, L, et al.
出版: (1996)

Targeted radionuclide therapy for neuroendocrine tumours: principles and application.
由: Druce, MR, et al.
出版: (2010)

MRI of pancreatic neuroendocrine tumours.
由: Owen, N, et al.
出版: (2001)

Radiolabeling Technique of Silver Nanoparticles (AgNPs) with Iodine-131 Radionuclide
由: U.N. Sholikhah, et al.
出版: (2020-08-01)

Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours.
由: Kaltsas, G, et al.
出版: (2004)

Radionuclide imaging of neuroendocrine tumors
由: Šaponjski Jelena, et al.
出版: (2020-01-01)

Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titration.
由: Jenkins, P, et al.
出版: (2000)

Modular strategic SMT solving with SMT-RAT
由: Kremer Gereon, et al.
出版: (2018-08-01)

The role of somatostatin analogues in the treatment of neuroendocrine tumours.
由: Grozinsky-Glasberg, S, et al.
出版: (2008)

Radiolabeled Dendrimer Coated Nanoparticles for Radionuclide Imaging and Therapy: A Systematic Review
由: Miriam Conte, et al.
出版: (2023-03-01)

RADIONUCLIDE IMAGING AND THERAPY OF NEUROENDOCRINE TUMOURS
由: Shaunak Navalkissoor, et al.
出版: (2015-11-01)

Pituitary imaging using a labelled somatostatin analogue in acromegaly.
由: Ur, E, et al.
出版: (1992)

Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms.
由: Grozinsky-Glasberg, S, et al.
出版: (2008)

Familial paraganglioma: a novel presentation of a case and response to therapy with radiolabelled MIBG.
由: Lawrence, J, et al.
出版: (2004)

Treatment of advanced neuroendocrine tumours using combination chemotherapy with lomustine and 5-fluorouracil.
由: Kaltsas, G, et al.
出版: (2002)

Ytrium 90 as a radionuclide for therapy
由: Alejandro Alberti Ramírez
出版: (2012-07-01)

487 Abstract withdrawn
出版: (2023-11-01)

Radionuclide imaging and therapy in patients with neuroendocrine tumors
由: Olga D. Baranova, et al.
出版: (2018-03-01)

The role of 123I-diagnostic imaging in the follow-up of patients with differentiated thyroid carcinoma as compared to 131I-scanning: avoidance of negative therapeutic uptake due to stunning.
由: Siddiqi, A, et al.
出版: (2001)

Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours
由: Marianne S. Elston, et al.
出版: (2021-12-01)

Neuroendocrine Tumours : From Radiomolecular Imaging to Radionuclide Therapy
由: GEORGIOS eLIMOURIS
出版: (2012-02-01)

The diagnosis and medical management of advanced neuroendocrine tumors.
由: Kaltsas, G, et al.
出版: (2004)

The development, commercialization, and clinical context of yttrium-90 radiolabeled resin and glass microspheres
由: Mark A. Westcott, MD, et al.
出版: (2016-10-01)

Physiologically Based Pharmacokinetic (PBPK) model for biodistribution of radiolabeled peptides in patients with neuroendocrine tumours
由: Viktor Popov, et al.
出版: (2016-07-01)

Successful neoadjuvant peptide receptor radionuclide therapy for an inoperable pancreatic neuroendocrine tumour
由: Tiago Nunes da Silva, et al.
出版: (2018-04-01)

Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
由: Korbonits, M, et al.
出版: (1998)

Evaluation of carrier added (CA) and no carrier added (NCA) 177Lu radionuclide roles in radiolabeling of peptide groups
由: S. Vosoughi, et al.
出版: (2020-11-01)

Peptide receptor radionuclide therapy of neuroendocrine tumors: Case series
由: Matović Milovan
出版: (2012-01-01)

I-123 imaging for the prediction of I-131 therapy for recurrent differentiated thyroid cancer, RDTC, when I-131 tracer is negative but raised thyroglobulin, Tg
由: Britton, K, et al.
出版: (1999)

Spinal cord compression after radiolabeled metaiodobenzylguanidine analogue therapy in advanced malignant insulinoma
由: Alina Coutinho Rodrigues Feitosa, et al.

The traceless Staudinger ligation for indirect 18F-radiolabelling.
由: Carroll, L, et al.
出版: (2011)

487 peserta sertai Webinar Antarabangsa
由: Isa, Siti Suriawati, et al.
出版: (2020)

Detection of neuroendocrine liver metastases with MnDPDP-enhanced MRI.
由: Rockall, A, et al.
出版: (2009)